Signature Estate & Investment Advisors LLC increased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,596 shares of the medical research company’s stock after purchasing an additional 819 […]
Signature Estate & Investment Advisors LLC boosted its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.6% during the 2nd quarter, Holdings Channel.com reports. The firm owned 11,596 shares of the medical research company’s stock after purchasing an additional 819 shares during the period. Signature Estate & Investment Advisors LLC’s holdings […]
Norris Perne & French LLP MI grew its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 1.2% in the 2nd quarter, Holdings Channel reports. The institutional investor owned 102,813 shares of the medical research company’s stock after buying an additional 1,267 shares during the quarter. Charles River Laboratories International […]
Charles River Laboratories International (NYSE:CRL – Free Report) had its price objective trimmed by Robert W. Baird from $267.00 to $256.00 in a report issued on Friday, MarketBeat.com reports. The firm currently has an outperform rating on the medical research company’s stock. Several other equities research analysts have also weighed in on the company. Bank […]
Charles River Laboratories International (NYSE:CRL – Free Report) had its price objective reduced by Bank of America from $245.00 to $230.00 in a report issued on Friday morning, FlyOnTheWall reports. Other equities research analysts have also recently issued research reports about the company. TD Cowen initiated coverage on Charles River Laboratories International in a research […]